Finance

Lists
531349:BOM
Panacea Biotec Ltd
359,70 INR
+0,93%
(+3,30) 1D
16 ოქტ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 531349...
Open
354,35 INR
High
363,70 INR
Low
354,35 INR
Mkt. cap
22,05 მლრდ.
Avg. vol.
4,95 ათ.
Volume
1,47 ათ.
52-wk high
647,50 INR
52-wk low
293,10 INR
EPS
-1,16 INR
Shares outstanding
61,25 მლნ.
No. of employees
2 ათ.
Open
354,35 INR
High
363,70 INR
Low
354,35 INR
Mkt. cap
22,05 მლრდ.
Avg. vol.
4,95 ათ.
Volume
1,47 ათ.
52-wk high
647,50 INR
52-wk low
293,10 INR
EPS
-1,16 INR
Shares outstanding
61,25 მლნ.
No. of employees
2 ათ.
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
41 წუთის წინ
Phase 3 Lung Trials Could Be A Big Test For Insmed (INSM)
Yahoo Finance
Yahoo Finance
·
1 საათის წინ
Dow (DOW) Stock Could Look Reasonable After a 43% Gain
Profile
Panacea Biotec is a global generic and specialty pharmaceutical and vaccine maker. It has principal offices in New Delhi, Mumbai, and Lalru. It has business interests in research, development, manufacturing and marketing of pharmaceutical formulations, vaccines, biosimilars, and natural products. Wikipedia
About Panacea Biotec Ltd
CEO-
Employees2,1 ათ.
Founded1984
Headquarters-
Sector-
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
1,41 მლრდ.
1,65 მლრდ.
1,67 მლრდ.
2,00 მლრდ.
Cost of goods sold
589,40 მლნ.
679,30 მლნ.
763,93 მლნ.
1,02 მლრდ.
Cost of revenue
589,40 მლნ.
679,30 მლნ.
763,93 მლნ.
1,02 მლრდ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
477,10 მლნ.
405,30 მლნ.
607,88 მლნ.
441,60 მლნ.
Operating expense
1,08 მლრდ.
939,70 მლნ.
849,37 მლნ.
1,00 მლრდ.
Total operating expenses
1,67 მლრდ.
1,62 მლრდ.
1,61 მლრდ.
2,02 მლრდ.
Operating income
-261,30 მლნ.
32,90 მლნ.
54,24 მლნ.
-22,30 მლნ.
Other non operating income
64,00 მლნ.
22,80 მლნ.
-149,85 მლნ.
42,40 მლნ.
EBT including unusual items
-191,70 მლნ.
64,90 მლნ.
-12,49 მლნ.
35,70 მლნ.
EBT excluding unusual items
-218,70 მლნ.
37,20 მლნ.
-47,72 მლნ.
8,30 მლნ.
Income tax expense
-51,60 მლნ.
26,00 მლნ.
-2,46 მლნ.
13,70 მლნ.
Effective tax rate
26,92%
40,06%
19,70%
38,38%
Other operating expenses
522,70 მლნ.
449,90 მლნ.
162,69 მლნ.
480,30 მლნ.
Net income
-139,20 მლნ.
39,80 მლნ.
5,13 მლნ.
23,00 მლნ.
Net profit margin
-9,86%
2,41%
0,31%
1,15%
Earnings per share
-
-
-
-
Interest and investment income
-
-
41,64 მლნ.
-
Interest expense
-21,40 მლნ.
-18,50 მლნ.
-5,60 მლნ.
-11,80 მლნ.
Net interest expenses
-21,40 მლნ.
-18,50 მლნ.
36,04 მლნ.
-11,80 მლნ.
Depreciation and amortization charges
83,40 მლნ.
84,50 მლნ.
78,80 მლნ.
79,00 მლნ.
EBITDA
-177,60 მლნ.
113,44 მლნ.
129,51 მლნ.
60,35 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები